Sartorius (ETR:SRT) Reaches New 1-Year High at $165.00

Sartorius AG (ETR:SRT) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as €165.00 ($191.86) and last traded at €163.00 ($189.53), with a volume of 583 shares changing hands. The stock had previously closed at €162.00 ($188.37).

The firm has a market cap of $11.18 billion and a PE ratio of 73.29. The company has a current ratio of 1.37, a quick ratio of 0.70 and a debt-to-equity ratio of 104.18.

COPYRIGHT VIOLATION WARNING: “Sartorius (ETR:SRT) Reaches New 1-Year High at $165.00” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at

About Sartorius (ETR:SRT)

Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors.

Read More: What is a good rate of return for a mutual fund?

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with's FREE daily email newsletter.